When building the capabilities for our company to continue progressing our drug-device combination product through a phase II dose finding study as well as a clinical validation program, we sought after a research organization that we could build a long term partnership across multiple phases and aspects of our development program. CSSi LifeSciences was that team that was able to provide critical strategic insights into all our study designs, execute the study to stay on time on budget during the COVID-19 pandemic and produced high quality, scientific reports summarizing the study and results.
During this time of being thankful, I’d be remiss if I didn’t stress how thankful I am for you and your team at CSSi. Your guidance and working with your group is one of the highlights of my year.
Many thanks to you and the CSSi team for all of your diligence and hard work making our IND submission to the FDA a success.
The CSSi LifeSciences team has done a phenomenal job helping us. Their insights and logic have been spot-on, and their work has been fantastic. As always, everything they’ve done to help us is greatly appreciated and that is why I trust them with my matters for Constellation Medical. They are consummate professionals, well versed in their subjects and regulatory procedures, and responsive to client requests and needs.
CSSI have been dedicated and hard-working partners in Spring’s clinical efforts. Their team has helped us creatively solve many logistical challenges with a commitment to quality, safety, and speed.
Thanks to everyone for your efforts on this orphan drug designation initiative. This is a (potentially) very exciting new development for our company.